Meet us at Exhibitor Booth 14114
OracleBio’s CSO Lorcan Sherry and Clinical Operations Manager, Alison Bigley, will be attending the American Society of Clinical Oncology (ASCO) congress 2016 in Chicago from June 3rd – 7th. OracleBio will have an exhibitor booth at positon 14114 in the Oncology Professionals Hall from 2pm on Saturday 3rd through to 5pm Monday 6th.
- OracleBio combines over 75 years of Pharma R&D experience with expertise in the principles and application of histology image analysis within Oncology research, with an overall focus on the delivery of assured, robust data in support of R&D processes.
- Our services can help deliver detailed exploratory biomarker data as part of your clinical oncology trial, confirm the Mechanism of Action of your therapy within the tumor microenvironment and improve translation and decision making between pre-clinical and clinical studies.
- Find out how we engage with our pathologist network to combine interactive digital annotation of tumor tissue with our powerful image analysis capabilities.
- Hear about our track record of working alongside Pharma on clinical oncology studies and a recent study we performed for a US-based Pharma, which generated a range therapeutic related biomarker read-outs and was published in the Lancet in November 2015.
Please contact us to arrange a meeting during the congress.
The Annual Meeting brings together 30,000 oncology professionals from around the world. Educational sessions feature world-renowned faculty discussing state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Science sessions present the latest ground-breaking research in oral and poster format. The theme for ASCO 2016 is Collective Wisdom: The Future of Patient-Centered Care and Research. Spanning disciplines, disease sites, and treatment approaches, it is our combined knowledge that will shape the future of patient care and research. For more information on the congress please visit http://am.asco.org/